Literature DB >> 12496433

Lack of C3 affects Th2 response development and the sequelae of chemotherapy in schistosomiasis.

Anne Camille La Flamme1, Andrew S MacDonald, Clive R Huxtable, Michael Carroll, Edward J Pearce.   

Abstract

The role of the third component of complement (C3) during schistosome infection was investigated using mice deficient in C3. While no effect was observed 8 wk after infection on worm development or liver pathology, Ag-specific Th2-associated cytokine production (IL-13, IL-5, IL-6, and IL-10) was significantly reduced, and IFN-gamma production was enhanced in the absence of C3. IgG1 and IgE, but not IgG2a or IgM, Ab responses were also significantly impaired in infected C3(-/-) mice, suggesting that C3 may play a role in IL-4-mediated Th2 response enhancement during schistosome infection. Furthermore, C3-deficient mice could not effectively clear adult worms after praziquantel (PZQ) treatment and suffered increased morbidity due to the overproduction of proinflammatory mediators following drug administration. However, the ischemic liver damage that normally accompanies PZQ administration in infected wild-type mice was substantially reduced in treated C3-deficient mice, probably due to the absence of dead or dying worms in the livers of these animals. Together these results indicate that C3 enhances Th2 responses during schistosome infection, potentiates PZQ-mediated parasite clearance, and reduces chemotherapy-induced proinflammatory mediator production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496433     DOI: 10.4049/jimmunol.170.1.470

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  Regulation of granulomatous inflammation in experimental models of schistosomiasis.

Authors:  Abram B Stavitsky
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 2.  The effect of locally synthesised complement on acute renal allograft rejection.

Authors:  Steven Sacks; Wuding Zhou
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

3.  The landscape of human genes involved in the immune response to parasitic worms.

Authors:  Matteo Fumagalli; Uberto Pozzoli; Rachele Cagliani; Giacomo P Comi; Nereo Bresolin; Mario Clerici; Manuela Sironi
Journal:  BMC Evol Biol       Date:  2010-08-31       Impact factor: 3.260

4.  A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice.

Authors:  Songqing He; Carl Atkinson; Fei Qiao; Katherine Cianflone; Xiaoping Chen; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

Review 5.  Subversion of complement by hematophagous parasites.

Authors:  Hélène Schroeder; Patrick J Skelly; Peter F Zipfel; Bertrand Losson; Alain Vanderplasschen
Journal:  Dev Comp Immunol       Date:  2009       Impact factor: 3.636

Review 6.  The innate allergenicity of helminth parasites.

Authors:  Franco H Falcone; Alex Loukas; Rupert J Quinnell; David I Pritchard
Journal:  Clin Rev Allergy Immunol       Date:  2004-02       Impact factor: 8.667

7.  Complement plays a minimal role in Sm-p80-mediated protection against Schistosoma mansoni.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Mayeen U Alam; Richard Winn; Workineh Torben; Loc Le; Kory A Tillery; Afzal A Siddiqui
Journal:  Hum Vaccin Immunother       Date:  2013-12-27       Impact factor: 3.452

8.  Host-Specific Serum Factors Control the Development and Survival of Schistosoma mansoni.

Authors:  Sören Frahm; Ulrich Fabien Prodjinotho; Sonakshi Bhattacharjee; Admar Verschoor; Clarissa Prazeres da Costa
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

9.  MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection.

Authors:  Pengfei Cai; Xianyu Piao; Shuai Liu; Nan Hou; Heng Wang; Qijun Chen
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

10.  The biology of nematode- and IL4Rα-dependent murine macrophage polarization in vivo as defined by RNA-Seq and targeted lipidomics.

Authors:  Graham D Thomas; Dominik Rückerl; Benjamin H Maskrey; Phillip D Whitfield; Mark L Blaxter; Judith E Allen
Journal:  Blood       Date:  2012-10-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.